TP53 codon 72 polymorphism in patients with chronic lymphocytic leukaemia: Identification of a subgroup with mutated IGHV genes and poor clinical outcome

British Journal of Haematology

Volumn 153, Issue 4, 2011, Pages 533-535

  Majid, Aneela ^a   Richards, Tom ^a   Dusanjh, Palminder ^a   Kennedy, D Benjamin J ^a   Miall, Fiona ^a   Gesk, Stefan ^b   Siebert, Reiner ^b   Wagner, Simon D ^a   Dyer, Martin J S ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

CLL; Polymorphism; TP53

Indexed keywords

ARGININE; PROLINE; PROTEIN MDM2; PROTEIN P53;

CANCER CLASSIFICATION; CANCER GROWTH; CANCER SURVIVAL; CELL CYCLE PROGRESSION; CHRONIC LYMPHATIC LEUKEMIA; CODON; GENE; GENE DELETION; GENE FREQUENCY; GENE MUTATION; GENETIC ASSOCIATION; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; IGHV GENE; IMMUNOPHENOTYPING; LETTER; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; SINGLE NUCLEOTIDE POLYMORPHISM; TP53 GENE;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; GENES, IMMUNOGLOBULIN HEAVY CHAIN; GENES, P53; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; MIDDLE AGED; MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS;

EID: 79955022813     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2010.08484.x     Document Type: Letter

References (8)

1. Crowther-Swanepoel, D. & Houlston, R.S. (2009) The molecular basis of familial chronic lymphocytic leukemia. Haematologica, 94, 606-609.
2. Dumont, P., Leu, J.I., Della Pietra, A.C. 3rd, George, D.L. & Murphy, M. (2003) The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nature Genetics, 33, 357-365.
3. Kochethu, G., Delgado, J., Pepper, C., Starczynski, J., Hooper, L., Krishnan, S., Fegan, C. & Pratt, G. (2006) Two germ line polymorphisms of the tumour suppressor gene p53 may influence the biology of chronic lymphocytic leukaemia. Leukemia Research, 30, 1113-1118.
4. Orsted, D.D., Bojesen, S.E., Tybjaerg-Hansen, A. & Nordestgaard, B.G. (2007) Tumor suppressor p53 Arg72Pro polymorphism and longevity, cancer survival, and risk of cancer in the general population. The Journal of Experimental Medicine, 204, 1295-1301.
5. Pim, D. & Banks, L. (2004) p53 polymorphic variants at codon 72 exert different effects on cell cycle progression. International Journal of Cancer, 108, 196-199.
6. Sjalander, A., Birgander, R., Kivela, A. & Beckman, G. (1995) p53 polymorphisms and haplotypes in different ethnic groups. Human Heredity, 45, 144-149.
7. Sturm, I., Bosanquet, A.G., Hummel, M., Dörken, B. & Daniel, P.T. (2005) In B-CLL, the codon 72 polymorphic variants of p53 are not related to drug resistance and disease prognosis. BMC Cancer, 5, 105-109.
8. Tobin, G., Thunberg, U., Johnson, A., Thorn, I., Soderberg, O., Hultdin, M., Botling, J., Enblad, G., Sallstrom, J., Sundstrom, C., Roos, G. & Rosenquist, R. (2002) Somatically mutated Ig V(H)3-21 genes characterize a new subset of chronic lymphocytic leukemia. Blood, 99, 2262-2264.